Key terms
About MEIP
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MEIP news
Apr 11
8:11am ET
MEI Pharma prioritizes voruciclib, will not continue with 2nd ROC
Apr 11
8:06am ET
MEI Pharma reports data from study evaluating ME-344/Avastin combo for mCRC
Feb 21
4:14pm ET
MEI Pharma Announces Flexible $25 Million Funding Strategy
Feb 20
5:35pm ET
MEI Pharma files $100M mixed securities shelf
Feb 14
7:41am ET
MEI Pharma price target lowered to $7 from $8 at Stifel
No recent press releases are available for MEIP
MEIP Financials
Key terms
Ad Feedback
MEIP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MEIP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range